Search
Displaying 781–790 of 853 results for “vision connection”
-
Genentech’s Faricimab Performs Well in Phase 3 Clinical Trials for Wet AMD
Research NewsCompany will seek marketing approval for the emerging therapy
-
ProQR Completes Enrollment in Phase 2/3 Clinical Trial of RNA Therapy for LCA10
Research NewsCompany also announced progress in enrollment for Phase 1 / 2 clinical trials for emerging USH2A and RHO RNA therapies.
-
REGENXBIO’s Wet AMD Gene Therapy Moving into Phase 3 Trials
Research NewsIn a Phase ½ clinical trial, the emerging treatment reduced the burden of regular anti-VEGF injections
-
In the Press
Round was led by Sofinnova Investments with participation from Abingworth, Lightstone Ventures and all existing investors.
Company expands board of directors and plans to build out team.
-
Don’t Let Others Tell You What You Can’t Do
Beacon StoriesNaheda, a brilliant scientist, has never let her visual impairment stop her from accomplishing her goals and encourages other students with disabilities not to be intimidated by difficult situations. Her story underscores how important it is to ask for help when needed to achieve success.
-
“Together, We’re Winning” the Fight Against Blinding Diseases
Foundation NewsFoundation Fighting Blindness Launches New Campaign
-
An Eye on Education Video Series
Learn all about inherited retinal diseases and related science topics by watching (or listening to) the Foundation’s educational video series developed for patients, families, and other lay audiences.
-
Foundation News
This exclusive conversation and acoustic performance by Sam and Casey Harris of X Ambassadors on August 20, will raise awareness and funds to find treatments and cures for blinding diseases.
-
In the Press
Company formed with $8.15 million Series 1; led by founding investors Hatteras Venture Partners and the Foundation Fighting Blindness
-
Foundation News
Accepting grant applications for advancing retinal degeneration treatments toward human studies
